Found 25 news articles for Ovarian cancer

Order by most

Recent Relevant
  • Ovarian cancer treatment hope

    Hudson Institute researchers have shown for the first time that a diabetes drug called sitagliptin can limit tumour growth, and possibly extend survival rates from epithelial ovarian cancer, the most……  Read more

    Dr Amy Wilson at Hudson Institute
  • NHMRC Ideas Grants success

    Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million. Ideas Grants fund innovative and creative……  Read more

    Sam, Paul, Ed and Vince, Hudson Institute's successful NHMRC Ideas Grants recipients
  • $2.2 million awarded to tackle rare ovarian cancer

    Women with a rare and potentially aggressive form of ovarian cancer will benefit from a grant to continue ground-breaking research into new detection and treatment methods. Dr Simon Chu Led……  Read more

    Professor Peter Fuller AM and Dr Simon at the Hudson Institute of Medical Research
  • Simple blood test can improve ovarian cancer diagnosis

    Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer. Ovarian cancer is one of the most common gynaecologic cancers,……  Read more

    Dr Andrew Stephens from the Ovarian Cancer Biomarkers Research Group at Hudson Institute
  • Congratulations to our CASS Foundation grant awardees

    Five Hudson Institute researchers have been awarded one-year Medicine/Science grants totalling nearly $300,000 by The CASS Foundation, to advance their research projects into mitochondrially-driven cancers, ovarian cancer, Parkinson’s disease, primary……  Read more

    2020 Successful CASS Foundation Grants applicants
  • Researchers frock up for Frocktober

    For the month of ‘frocktober’ ovarian cancer researchers, Dr Maree Bilandzic and Dr Amy Wilson swapped their white lab coats for colourful frocks as part of the Frocktober campaign to……  Read more

    Dr Amy Wilson and Dr Maree Bilandzic all dressed up in the lab in stunning dresses, supporting OCRF Frocktober
  • Ovarian cancer ‘invasion cells’ identified

    Highly mobile, invasive ovarian cancer cells called ‘leader cells’ have been identified as leading the attack on healthy tissue. Dr Maree Bilandzic explains this pivotal discovery, published in Cancers, and……  Read more

    Dr Maree Bilandzic from the Ovarian Cancer Biomarkers Research Group at Hudson Institute investigates the deadliest ovarian cancer cells
  • Ivanhoe Girls’ Grammar School raise ovarian cancer funds

    A group of 26 students from Ivanhoe Girls’ Grammar School have fundraised to create the school’s inaugural Early Career Ovarian Cancer Research Travel Award, which has been awarded to Hudson……  Read more

    Students & winner display the Early Career Ovarian Cancer Research Travel Award
  • Funding to combat deadly ovarian cancer

    Dr Maree Bilandzic has been awarded $700,000 to progress research to target rogue cancer cells called ‘leader cells’. The announcement is part of $2.2 million awarded by the Ovarian Cancer……  Read more

    Dr Maree Bilandzic from the Ovarian Cancer Biomarkers Research Group at Hudson Institute investigates the deadliest ovarian cancer cells
  • 2019 IMPACT Philanthropy – Perpetual

    Two Hudson Institute researchers, Dr Jun Yang and Dr Maree Bilandzic have been successful in the 2019 IMPACT Philanthropy program, from Perpetual, which are awarded to organisations based on their……  Read more

    Dr Maree Bilandzic and Dr Jun Yang at Hudson Institute of Medical Research